Lupin shares have gained for eight consecutive trading sessions as of Tuesday's close. The last time the stock gained for ...

Lupin’s shares rose 2.8% in afternoon trading after the company received a key U.S. Food and Drug Administration (FDA) ...

Lupin has bagged the approval for Lenalidomide capsules. This drug is used in the treatment of Multiple Myeloma (MM). In an ...

Drugmaker Lupin said it has received the USFDA's approval for Risperidone for extended-release injectable suspension ...

The capsules will be available in 2.5 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 25 mg strengths and are bioequivalent to REVLIMID(R) capsules of Bristol-Myers Squibb Company. The product will be manufactured ...

This comes just weeks after Lupin secured USFDA approval for its Risperidone Injectable, used to treat schizophrenia and ...